DANISH BIO COMMODITIES A/S: Financial statements 2022
CVR: 40594264
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
DANISH BIO COMMODITIES A/S (CVR 40594264) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 7,850,259 and a net result of DKK 1,471,151 compared with DKK -754,906 the year before. That is an increase of 209.6% compared with the year before. Equity in the 2022 report amounted to DKK 4,774,883. The solvency ratio was 17.7%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 7,850,259
- Profit/Loss
- DKK 1,471,151
- Equity
- DKK 4,774,883
- Total Assets
- DKK 27,043,843
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 7.9 mio. | 1.5 mio. | 4.8 mio. | 4 |
| 2021 | - | 2.5 mio. | -755 t. | 3.3 mio. | 4 |
| 2020 | - | -313 t. | -1 mio. | -141 t. | 2 |
Official annual report
Keep an eye on DANISH BIO COMMODITIES A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
DANISH BIO COMMODITIES A/S has published its annual report for 2021. Gross profit came to DKK 2,535,349, and the net result was DKK -754,906.
About DANISH BIO COMMODITIES A/S
DANISH BIO COMMODITIES A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2019. The company is registered under the industry Mægler- og agentaktiviteter i forbindelse med forsyning af elektricitet og naturgas. The management consists of Rune Ledgaard Sørensen. The board consists of Miika Samuel Johansson (chair), Aleksi Juhani Graan and Sakari Olli Iisakki Muroke. The company is owned by DBC Group Holding ApS. The company has 20 employees (2026). In 2025, the company reported a gross profit of DKK 27,240,712 and a net result of DKK 4,745,983 compared with DKK -1,059,967 the year before. Equity in the 2025 report amounted to DKK 66,680,402.